A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

In Ecotoxicology and Environmental Safety, researchers highlight a multitude of studies on endocrine disrupting chemicals ...

Researchers identified genes that could explain why some assisted reproductive technologies, like IVF, carry a higher risk of growth and metabolic issues in offspring.

Past psychology research suggests that there is a strong relationship between difficult experiences during childhood and the ...

In the exploration of aging and health outcomes, epigenetic clocks have emerged as crucial biomarkers. Predominantly developed from data pertaining to ...

Diabetes is a leading cause of global mortality and disability, and its economic burden is substantial. This Review focuses on type 2 diabetes, which makes up 90–95% of all diabetes cases. Type 2 ...

If the development of blood vessels in the placenta is impaired, fetal growth retardation may result. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of ...

Its lead candidate Tune-401, which aims to repress viral DNA that contributes to infection, has entered into clinical trials in New Zealand and Hong Kong.

Investors clearly appreciate the song Tune Therapeutics is singing, handing over $175 million in series B funds as the ...

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...